The Future of UK Drug Pricing: The 2014 PPRS - An Interim Review

Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

 

Previous Article
FDA Orphan Exploitation? Are Pharma's Approaches to Orphan Oncology Drug Approvals Fuelling A Push for Reform by the FDA?
FDA Orphan Exploitation? Are Pharma's Approaches to Orphan Oncology Drug Approvals Fuelling A Push for Reform by the FDA?

Next Article
Managed Access Agreements: A New Model Pathway For Reimbursement of Non-Oncology Drugs in England Approved Under European Adaptive Pathways?
Managed Access Agreements: A New Model Pathway For Reimbursement of Non-Oncology Drugs in England Approved Under European Adaptive Pathways?

Educational poster presented at ISPOR 20th Annual European Congress, November 2017.